Classification, early screening and treatment of severe combined immunodeficiency disease
10.3760/cma.j.issn.1673-4408.2021.02.012
- VernacularTitle:重症联合免疫缺陷病的分类、早期筛查及治疗
- Author:
Yijun WU
;
Haiguo YU
;
Yongjun FANG
- From:
International Journal of Pediatrics
2021;48(2):122-126
- CountryChina
- Language:Chinese
-
Abstract:
Severe combined immunodeficiency(SCID)is a kind of severe primary immunodeficiency disease.Patients often develop symptoms after birth, which is characterized by recurrent and life-threatening infection, sometimes accompanied by varying degrees of dysplasia.According to the classification proposed by the PID expert Committee of the International Union of Immunological Societies, SCID is clinically classified by the number of lymphocytes.Early screening and intervention of SCID is significant to improve the prognosis.With the promotion of TREC and other early screening methods, the detection rate of SCID has significantly improved, but the accurate detection rate in different ethnic groups still needs further explored.Hematopoietic stem cell transplantation is a traditional therapy for radical cure of SCID.And the safety of gene therapy for SCID has been gradually guaranteed with continuous improvement during recent years.This article will review the classification, early screening methods and treatment progress of SCID.
